Indication

High-Risk Hematologic Malignancy

1 clinical trial

1 product

Clinical trial

A Phase II Open-label Study of ECT-001-expanded Cord Blood Transplantation in Patients With High-risk Acute Leukemia/Myelodysplasia

Status: Active (not recruiting), Estimated PCD: 2024-10-01

Product